|
1
|
Kosaka T, Yatabe Y, Endoh H, Kuwano H,
Takahashi T and Mitsudomi T: Mutations of the epidermal growth
factor receptor gene in lung cancer: biological and clinical
implications. Cancer Res. 64:8919–8923. 2004. View Article : Google Scholar
|
|
2
|
Paez JG, Janne PA, Lee JC, Tracy S,
Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, et
al: EGFR mutations in lung cancer: correlation with clinical
response to gefitinib therapy. Science. 304:1497–1500. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tokumo M, Toyooka S, Kiura K, Shigematsu
H, Tomii K, Aoe M, Ichimura K, Tsuda T, Yano M, Tsukuda K, et al:
The relationship between epidermal growth factor receptor mutations
and clinicopathologic features in non-small cell lung cancers. Clin
Cancer Res. 11:1167–1173. 2005.PubMed/NCBI
|
|
4
|
Asano H, Toyooka S, Tokumo M, Ichimura K,
Aoe K, Ito S, Tsukuda K, Ouchida M, Aoe M, Katayama H, et al:
Detection of EGFR gene mutation in lung cancer by mutant-enriched
polymerase chain reaction assay. Clin Cancer Res. 12:43–48. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shih JY, Gow CH, Yu CJ, Yang CH, Chang YL,
Tsai MF, Hsu YC, Chen KY, Su WP and Yang PC: Epidermal growth
factor receptor mutations in needle biopsy/aspiration samples
predict response to gefitinib therapy and survival of patients with
advanced nonsmall cell lung cancer. Int J Cancer. 118:963–969.
2006. View Article : Google Scholar
|
|
6
|
Soh J, Toyooka S, Aoe K, Asano H, Ichihara
S, Katayama H, Hiraki A, Kiura K, Aoe M, Sano Y, et al: Usefulness
of EGFR mutation screening in pleural fluid to predict the clinical
outcome of gefitinib treated patients with lung cancer. Int J
Cancer. 119:2353–2358. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Otani H, Toyooka S, Soh J, Yamamoto H,
Suehisa H, Kobayashi N, Gobara H, Mimura H, Kiura K, Sano Y, et al:
Detection of EGFR gene mutations using the wash fluid of CT-guided
biopsy needle in NSCLC patients. J Thorac Oncol. 3:472–476. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tang X, Shigematsu H, Bekele BN, Roth JA,
Minna JD, Hong WK, Gazdar AF and Wistuba II: EGFR tyrosine kinase
domain mutations are detected in histologically normal respiratory
epithelium in lung cancer patients. Cancer Res. 65:7568–7572.
2005.PubMed/NCBI
|
|
9
|
Edey AJ and Hansell DM: Incidentally
detected small pulmonary nodules on CT. Clin Radiol. 64:872–884.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Uskul BT, Turker H, Gokce M, Kant A,
Arslan S and Turan FE: CT-guided transthoracic fine needle
aspiration of pulmonary lesions: accuracy and complications in 134
cases. Tuberk Toraks. 57:177–185. 2009.PubMed/NCBI
|
|
11
|
Hiraki T, Mimura H, Gobara H, Iguchi T,
Fujiwara H, Sakurai J, Matsui Y, Inoue D, Toyooka S, Sano Y, et al:
CT fluoroscopy-guided biopsy of 1,000 pulmonary lesions performed
with 20-gauge coaxial cutting needles: diagnostic yield and risk
factors for diagnostic failure. Chest. 136:1612–1617. 2009.
View Article : Google Scholar
|
|
12
|
Lynch TJ, Bell DW, Sordella R,
Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat
SM, Supko JG, Haluska FG, et al: Activating mutations in the
epidermal growth factor receptor underlying responsiveness of
non-small-cell lung cancer to gefitinib. N Engl J Med.
350:2129–2139. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Maemondo M, Inoue A, Kobayashi K, Sugawara
S, Oizumi S, Isobe H, Gemma A, Harada M, Yoshizawa H, Kinoshita I,
et al: Gefitinib or chemotherapy for non-small-cell lung cancer
with mutated EGFR. N Engl J Med. 362:2380–2388. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He C, Liu M, Zhou C, Zhang J, Ouyang M,
Zhong N and Xu J: Detection of epidermal growth factor receptor
mutations in plasma by mutant-enriched PCR assay for prediction of
the response to gefitinib in patients with non-small-cell lung
cancer. Int J Cancer. 125:2393–2399. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee JW, Soung YH, Kim SY, Park WS, Nam SW,
Lee JY, Yoo NJ and Lee SH: Absence of EGFR mutation in the kinase
domain in common human cancers besides non-small cell lung cancer.
Int J Cancer. 113:510–511. 2005. View Article : Google Scholar : PubMed/NCBI
|
